Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
25.00
-0.80 (-3.10%)
At close: May 15, 2026, 4:00 PM EDT
25.10
+0.10 (0.40%)
After-hours: May 15, 2026, 7:35 PM EDT
Ultragenyx Pharmaceutical Analyst Ratings
Total Analysts
20
Consensus Rating
Strong Buy
Price Target
$58.80
Upside
+135.20%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Maintains $27 → $26 | Hold | Maintains | $27 → $26 | +4.00% | May 8, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $52 → $43 | Strong Buy | Maintains | $52 → $43 | +72.00% | May 8, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $45 → $47 | Buy | Maintains | $45 → $47 | +88.00% | May 6, 2026 |
| Wedbush | Wedbush | Hold Maintains $27 → $26 | Hold | Maintains | $27 → $26 | +4.00% | May 6, 2026 |
| Barclays | Barclays | Buy Maintains $44 → $43 | Buy | Maintains | $44 → $43 | +72.00% | Apr 29, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $50 → $67 | Buy | Maintains | $50 → $67 | +168.00% | Apr 16, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $61 → $25 | Strong Buy → Hold | Downgrades | $61 → $25 | n/a | Mar 24, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $120 → $74 | Buy | Maintains | $120 → $74 | +196.00% | Mar 12, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $128 → $79 | Strong Buy | Maintains | $128 → $79 | +216.00% | Feb 18, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $37 → $34 | Buy | Maintains | $37 → $34 | +36.00% | Feb 18, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $39 → $37 | Buy | Maintains | $39 → $37 | +48.00% | Feb 17, 2026 |
| Wedbush | Wedbush | Hold Reiterates $25 | Hold | Reiterates | $25 | n/a | Feb 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $50 | Strong Buy | Maintains | $60 → $50 | +100.00% | Feb 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +140.00% | Feb 3, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $60 | Strong Buy | Maintains | $80 → $60 | +140.00% | Jan 5, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $64 → $52 | Strong Buy | Maintains | $64 → $52 | +108.00% | Jan 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.